| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0024-3205(98)00568-2 |
| P698 | PubMed publication ID | 10072192 |
| P2093 | author name string | Pasutto FM | |
| Mercer JR | |||
| Jamali F | |||
| Emami J | |||
| P2860 | cites work | Insulin degradation by human skeletal muscle | Q71468888 |
| Purification and Characterization of a Protease with Specificity for Insulin from Rat Muscle | Q71778363 | ||
| A randomized trial of hydroxychloroquine in early rheumatoid arthritis: the HERA Study | Q72524724 | ||
| Insulin degradation: mechanisms, products, and significance | Q28289497 | ||
| Effect of chloroquine on insulin and glucose homoeostasis in normal subjects and patients with non-insulin-dependent diabetes mellitus | Q34068803 | ||
| A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine following intravenous administration to healthy volunteers | Q34417966 | ||
| Lysosomal association of internalized 125I-insulin in isolated rat hepatocytes. Direct demonstration by quantitative electron microscopic autoradiography | Q37038758 | ||
| The potential role of lysosomes in tissue distribution of weak bases | Q39563115 | ||
| Insulin metabolism and degradation | Q40318035 | ||
| Clinical pharmacokinetics of slow-acting antirheumatic drugs | Q40619935 | ||
| Accelerated Insulin Degradation: An Alternate Mechanism for Insulin Resistance | Q41030978 | ||
| Enantioselective disposition of hydroxychloroquine after a single oral dose of the racemate to healthy subjects | Q41898692 | ||
| In vitro binding of chloroquine to rat muscle preparations | Q41914838 | ||
| Receptor-mediated 125I-labelled insulin degradation in the rat hepatocyte. Studies using chloroquine | Q41920673 | ||
| Chloroquine stimulation of insulin binding to IM-9 lymphocytes: evidence for action at a nonlysosomal site | Q41924095 | ||
| Hydroxychloroquine compared with placebo in rheumatoid arthritis. A randomized controlled trial | Q41936586 | ||
| Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus. A new job for an old drug? | Q41943988 | ||
| Hepatic processing of insulin. Characterization of differential inhibition by weak bases | Q41945927 | ||
| Degradation of insulin and proinsulin by various organ homogenates of rat. | Q48718867 | ||
| Insulin degradation I. Purification and properties of glutathione-insulin transhydrogenase of rat liver | Q54231139 | ||
| Analytical and semi-preparative high-performance liquid chromatographic separation and assay of hydroxychloroquine enantiomers | Q67578604 | ||
| Effect of receptor up-regulation on insulin pharmacokinetics in streptozotocin-treated diabetic rats | Q67936320 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | enantiomer | Q494483 |
| hydroxychloroquine | Q421094 | ||
| P304 | page(s) | 325-335 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Life Sciences | Q5256275 |
| P1476 | title | Inhibition of insulin metabolism by hydroxychloroquine and its enantiomers in cytosolic fraction of liver homogenates from healthy and diabetic rats | |
| P478 | volume | 64 |
| Q34389286 | A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role |
| Q91828431 | COVID-19 and diabetes: Knowledge in progress |
| Q88917533 | Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis |
| Q34354276 | Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases |
| Q35013063 | Does atorvastatin work more effectively than biguanides in reducing cardiovascular risk factors? |
| Q33819280 | Effect of atorvastatin and hydroxychloroquine combination on blood glucose in alloxan-induced diabetic rats |
| Q35519392 | Hydroxychloroquine as a glucose lowering drug |
| Q88400696 | Hydroxychloroquine-induced hypoglycaemia in non-diabetic renal patient on peritoneal dialysis |
| Q37827403 | Hydroxychloroquine: from malaria to autoimmunity |
| Q94680079 | Parallel epidemics, or nearly so: certainties and uncertainties about sars-cov-2 in italy |
| Q52316454 | Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus. |
| Q35607534 | Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs. |
| Q41917902 | The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas--a randomized trial |
| Q38561490 | Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases |
| Q41942164 | Vascular elasticity of systemic lupus erythematosus patients is associated with steroids and hydroxychloroquine treatment |
Search more.